Influence of mammographic screening on trends in breast-conserving surgery in Ireland

European Journal of Cancer Prevention

Volumn 15, Issue 2, 2006, Pages 138-148

  Walsh, Paul M ^a   McCarron, Peter ^b   Middleton, Richard J ^b   Comber, Harry ^a   Gavin, Anna T ^b   Murray, Liam ^b  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Age; Breast cancer; Breast conserving surgery; Cancer stage; Mammography; Mastectomy; Screening; Surgery; Trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; IRELAND; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; ODDS RATIO;

EID: 33746582008     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000180668.96710.47     Document Type: Article

References (43)

1. Anon (2002). BreastCheck annual report, 2000-2001. Dublin: BreastCheck.
2. Barchielli A, Paci E, Giorgi D (1999). Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy. Cancer Causes Control 10:313-317.
3. Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP (2005). Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184:324-329.
4. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, (editors): (1992). Manual for staging of cancer, 4th edn. Philadelphia: Lippincott.
5. Campbell H (2002). The health of the public in Northern Ireland. Report of the Chief Medical Officer 2001. Belfast: Department of Health and Social Services; p. 113.
6. Campo J, Comber H, Gavin A (2004). All-Ireland cancer statistics 1998-2000. Belfast: Northern Ireland Cancer Registry and Cork: National Cancer Registry.
7. Codd MB, Laird OM, Dowling M, et al. (1994). Screening for breast cancer in Ireland: the Eccles Breast Screening Programme. Eur J Cancer Prev 3(Suppl 1):21-28.
8. Crawford MD, Biankin AV, Rickard MT, et al. (2000). The operative management of screen-detected breast cancers. Aust NZ J Surg 70:168-173.
9. de Koning HJ, van Dongen JA, van der Maas PJ (1994). Changes in use of breast-conserving therapy in the years 1978-2000. Br J Cancer 70:1165-1170.
10. Du X, Freeman DH Jr, Syblik DA (2000). What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Res Treat 62:71-79.
11. Ernst MG, Voogd AC, Coebergh JWW, et al. (2001). The introduction of mammographical screening has had little effect on the trend in breastconserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer 37:2435-2440.
12. Fisher B, Anderson S, Bryant J, et al. (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241.
13. Freedman GM, Anderson PR, Goldstein LJ, et al. (2003). Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer 98:918-925.
14. Gilligan MA, Kneusel RT, Hoffmann RG, et al. (2002). Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40:181-189.
15. Hebert-Croteau N, Brisson J, Latreille J, et al. (1999). Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951-955.
16. Hill DJ, White VM, Giles GG, et al. (1994). Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust 161:110-122.
17. Hislop TG, Coldman AJ, Olivotto IA, et al. (2003). Local and regional therapy for women with breast cancer in British Columbia. Breast J 9:192-199.
18. Hooning MJ, van Dongen JA, Went G (1991). Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation. Neth J Surg 43:102-104.
19. Innos K, Horn-Ross PL (2003). Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in Californian women. Cancer 97:1099-1106.
20. Lazovich D, Solomon CC, Thomas DB, et al. (1999). Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628-637.
21. McDermott EW (1997). Irish guidelines for surgeons in the management of breast cancer. Irish Society of Surgical Oncology. Ir Med J 90:6-10.
22. Morris CR, Cohen R, Schlag R, Wright WE (2000). Increasing trends in the use of breast conserving surgery in California. Am J Public Health 90:281-284.
23. National Cancer Institute (2004). Breast cancer (PDQs): Treatment. http://www.cancer.gov/cancerinfo/pdq/treatment/breast/healthprofessional/ [Accessed 18 March 2003]
24. National Coordination Group for Surgeons Working in Breast Cancer Screening (1996). Quality assurance guidelines for surgeons in breast cancer screening. Sheffield: NHS Breast Screening Programme.
25. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM (2000). Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356:1148-1153.
26. NicAmhlaoibh R, Mahmud S, Comber H (2004). Patterns of care and survival from cancer in Ireland 1994 to 1998. Cork: National Cancer Registry.
27. Olsen O, Gøtzsche PC (2001). Cochrane review on screening for breast cancer with mammography. Lancet 358:1340-1342.
28. Paci E, Duffy SW, Giorgi D, et al. (2002). Are breast cancer screening programmes increasing rates of mastectomy? Observational study. BMJ 325:418.
29. Percy C, Van Holten V, Muir C (1990). International classification of diseases for oncology, 2nd edn. Geneva: World Health Organization.
30. Richardson LC, Schulman J, Sever LE, et al. (2001). Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995. Breast Cancer Res Treat 69:133-142.
31. Sainsbury R, Rider L, Smith A, MacAdam A (1995). Does it matter where you live? Treatment variation in breast cancer in Yorkshire. Br J Cancer 71:1275-1278.
32. Sakorafas GH, Tsiotou AG (2000). Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Treat Rev 26:103-125.
33. Sant M, Eurocare Working Group (2001). Differences in stage and therapy for breast cancer across Europe. Int J Cancer 93:894-901.
34. Seiffert JE (editor): (1993). SEER program: comparative staging guide for cancer. Bethesda: National Institutes of Health.
35. Solin LJ, Legorreta A, Schultz DJ, et al. (1994). The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch Intern Med 154:745-752.
36. Swanson GM, Satariano ER, Satariano WA, Osuch JR (1990). Trends in conserving treatment of invasive carcinoma of the breast in females. Surg Gynecol Obstet 171:465-471.
37. Thornton H, Baum M, Gøtzsche PC, Spence D, Hall R, Moore RH, Paci E, Duffy SW (2002). Rapid Responses to: Paci E, Duffy SW, Giorgi D, et al. (2002). Are breast cancer screening programmes increasing rates of mastectomy? Observational study. BMJ 325:418. [on-line] http://bmj.bmjjournals.com/cgi/ eletters/325/7361/418 (18 March 2004). BMJ.com 24 August-24 October 2002
38. Tyldesley S, Foroudi F, Barbera L (2003). The appropriate rate of breast conserving surgery: an evidence-based estimate. Clin Oncol (R Coll Radiol) 15:144-155.
39. Vainio H, Bianchini F, (editors): (2002). IARC handbooks of cancer prevention, Vol 7. Breast cancer screening. Lyons: IARC Press; p. 148.
40. Veronesi U, Salvadori B, Luini A, et al. (1995). Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 31A:1574-1579.
41. Walsh PM, Comber H, Gavin AT (2001). All-Ireland cancer statistics 1994-96. Cork: National Cancer Registry (Ireland) and Belfast: Northern Ireland Cancer Registry.
42. Weiss MC, Fowble BL, Solin LJ, et al. (1992). Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 23:941-947.
43. Zhang J, Yu KF (1998). What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690-1691.